PE/TR Anti-Human CD4 Antibody[RPA-T4]

Introducing the PE/TR Anti-Human CD4 Antibody [RPA-T4], a highly reliable and efficient immunological tool designed for the specific detection and analysis of CD4 antigen expression in human samples. This antibody, conjugated with both PE (Phycoerythrin) and TR (Texas Red), offers enhanced versatility and flexibility in various experimental applications.

The PE/TR Anti-Human CD4 Antibody [RPA-T4] exhibits exceptional specificity and sensitivity, enabling precise identification and quantification of CD4-positive cells. Its advanced formulation ensures minimal background noise, resulting in accurate and reproducible results. This antibody is meticulously manufactured using cutting-edge techniques, guaranteeing batch-to-batch consistency and optimal performance.

With its dual conjugation of PE and TR, this antibody facilitates multiparametric flow cytometry analysis, allowing simultaneous detection of CD4 antigen alongside other markers of interest. Its compatibility with a wide range of flow cytometers ensures seamless integration into diverse laboratory settings. Moreover, the PE/TR Anti-Human CD4 Antibody [RPA-T4] is suitable for both research and clinical applications, making it an invaluable asset for immunologists, researchers, and healthcare professionals alike.

This product is supplied in a convenient and user-friendly format, ensuring ease of use and efficient workflow. Its long shelf life and stability guarantee prolonged usability, reducing the need for frequent reordering. Each vial contains a sufficient quantity of antibody, providing ample supply for multiple experiments.

In summary, the PE/TR Anti-Human CD4 Antibody [RPA-T4] offers exceptional performance, reliability, and versatility in the detection and analysis of CD4 antigen expression. Its advanced formulation, dual conjugation, and compatibility with various flow cytometers make it an indispensable tool for immunological research and clinical diagnostics. Experience the precision and accuracy of this antibody, and unlock new insights into CD4 biology.